Flash FDA approval sends ChemoCentryx spiralling upwardsChemoCentryx has claimed FDA approval for its avacopan drug for a rare autoimmune disease, becoming the first orally-active Share XFlash FDA approval sends ChemoCentryx spiralling upwardshttps://pharmaphorum.com/news/flash-fda-approval-sends-chemocentryx-spiralling-upwards/
